首页 › 基金 › MPM BioImpact LLC › TRAX

MPM BioImpact LLC 对 TRAX 的持仓历史

FIRST TRACKS BIOTHERAPEUTICS · 医疗保健

MPM BioImpact LLC 在 Q3 2026 的 13F 申报中披露持有 TRAX(FIRST TRACKS BIOTHERAPEUTICS)254,374 股,市值约 US$9.0M,约占其申报组合的 0.69%,在其申报持仓中市值排名第 36 位。 MPM BioImpact LLC 于 Q3 2026 首次申报该持仓。

最新持仓 (Q3 2026)254.37K 股
申报持仓市值$9.02M
组合权重0.69%
首次申报Q3 2026
最近变动新进
更新于2026-11-17

最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR

MPM BioImpact LLC 对 TRAX 的持仓演变

MPM BioImpact LLC 于 Q3 2026 首次披露 TRAX 持仓:254,374 股(约 US$9.0M)。

逐季持仓明细

季度股数金额变化
Q3 2026 254.37K $9.02M 新进

关于 TRAX 与 13F 数据

TRAX(FIRST TRACKS BIOTHERAPEUTICS)属于医疗保健行业。我们追踪的基金中还有 174 只申报持有 TRAX,申报仓位最大的包括:EcoR1 Capital, LLC (US$112.5M), TCG Crossover Management, LLC (US$102.6M), Affinity Asset Advisors, LLC (US$73.7M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 TRAX 的基金

查看 TRAX 的全部基金持有人 →

常见问题

How long has MPM BioImpact LLC held TRAX?

MPM BioImpact LLC has disclosed TRAX holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is MPM BioImpact LLC's current position in TRAX?

As of Q3 2026, MPM BioImpact LLC holds 254.37K shares of TRAX (FIRST TRACKS BIOTHERAPEUTICS), valued at $9.02M, representing 0.69% of its reported portfolio and ranking #36.

Has MPM BioImpact LLC been buying or selling TRAX?

In the latest 13F filing (Q3 2026), MPM BioImpact LLC newly opened its position in TRAX.

Which other funds hold TRAX?

Other major institutional holders of TRAX include EcoR1 Capital, LLC, TCG Crossover Management, LLC, Affinity Asset Advisors, LLC, among 174 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.